AdaptHealth officer granted 29,284 restricted shares

AdaptHealth Corp. reported that Chief Business Systems Officer Daniel McFadden received an award of 29,284 shares of common stock on 01/30/2026.

Rhea-AI Filing Summary

AdaptHealth Corp. reported that Chief Business Systems Officer Daniel McFadden received an award of 29,284 shares of common stock on 01/30/2026. The shares are in the form of restricted stock units that will convert into common stock when they vest.

Following this grant, McFadden beneficially owns 83,242 shares of AdaptHealth common stock in direct ownership. The award was reported at a price of $0 per share, consistent with a typical equity compensation grant rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 29,284 shares

Grant/Award 1 txn

Insider McFadden Daniel Edward

Role Chief Business Systems Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29,284	$0.00	$0.00

Holdings After Transaction: Common Stock — 83,242 shares (Direct)

Footnotes (1)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth (AHCO) report for Daniel McFadden?

AdaptHealth reported that Chief Business Systems Officer Daniel McFadden received 29,284 shares of common stock as a grant on January 30, 2026. These shares are structured as restricted stock units that will convert into common stock when vesting conditions are met.

How many AdaptHealth (AHCO) shares does Daniel McFadden own after this Form 4?

After the reported transaction, Daniel McFadden beneficially owns 83,242 shares of AdaptHealth common stock. This total reflects the addition of 29,284 restricted stock units granted on January 30, 2026, held as direct ownership according to the Form 4 filing.

What type of equity did Daniel McFadden receive from AdaptHealth (AHCO)?

Daniel McFadden received restricted stock units representing 29,284 shares of AdaptHealth common stock. The filing states these units will be settled in common stock upon vesting, indicating they are a form of stock-based compensation rather than immediate freely tradable shares.

Was there a purchase price for the AdaptHealth (AHCO) shares granted to Daniel McFadden?

The Form 4 lists the transaction price as $0.00 per share for the 29,284 shares granted. This reflects a compensatory award of restricted stock units, not an open-market purchase, meaning McFadden did not pay cash to acquire these units at grant.

Is Daniel McFadden considered an officer of AdaptHealth (AHCO) in this Form 4?

Yes. The Form 4 identifies Daniel McFadden as an officer of AdaptHealth with the title Chief Business Systems Officer. His role and status as an officer require public reporting of transactions in AdaptHealth common stock under Section 16 ownership rules.

Are the new AdaptHealth (AHCO) shares held directly by Daniel McFadden?

Yes. The Form 4 classifies McFadden’s ownership as direct, indicated by the code "D" in the ownership column. There is no footnote stating that an outside entity or trust holds the shares, so the filing attributes the beneficial ownership directly to him.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 08:20 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McFadden Daniel Edward

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Business Systems Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/30/2026		A		29,284(1)	A	$0	83,242	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 26, 2025 as an exhibit to the Form 3 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Daniel McFadden	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.